JHSM

Journal of Health Sciences and Medicine (JHSM) is an unbiased, peer-reviewed, and open access international medical journal. The Journal publishes interesting clinical and experimental research conducted in all fields of medicine, interesting case reports, and clinical images, invited reviews, editorials, letters, comments, and related knowledge.

EndNote Style
Index
Original Article
Safety, treatment adherence, and patient satisfaction in major ozone autohemotherapy: a single-center retrospective study
Aims: This study evaluated adverse events reported during and after major ozone autohemotherapy (MAHT), treatment adherence, and patient satisfaction, with particular emphasis on difficult venous access (DVA) in relation to adherence. Methods: This single-center, non-interventional, retrospective descriptive survey study included 240 patients aged ?18 years who underwent MAHT between January 2024 and November 2025. Approximately 100 ml of venous blood was used per session. Ozone concentration ranged from 15 to 35 µg/ml, and sessions were scheduled twice weekly. Results: Mean age was 53.1±12.4 years, and 68.8% of participants were female. The completion rate of planned sessions was 65.0% (156/240). Adverse events during treatment occurred in 11.3% of patients (27/240; 95% CI 7.8-15.9), and 88.9% were related to venous access or procedural factors. DVA was observed in 7.1% of the total sample (17/240) and in 63.0% of those reporting procedural adverse effects (17/27). Age ?60 years was associated with higher odds of DVA (OR=3.79; 95% CI 1.38-10.41). Post-treatment adverse effects occurred in 3.8% of patients (9/240; 95% CI 2.0-7.0). Procedural adverse events were associated with treatment non-completion (RR=2.63; p


1. International Scientific Committee of Ozone Therapy. Madrid declaration on ozone therapy: ISCO3, 3rd edition. Published 2020. Accessed March 9, 2026. https://isco3.org/madrid-declaration-on-ozone-therapy-isco3-3rd-edition-2020-103-pages/
2. International Scientific Committee of Ozone Therapy. Definitions of terms in ozone therapy. Published 2019. Accessed March 9, 2026. https://isco3.org/wp-content/uploads/2015/09/ISCO3-QAU-00-04-Definitios-and-terms-in-O3-Final.pdf
3. International Scientific Committee of Ozone Therapy. Major autohemotherapy. Published October 3, 2016. Accessed March 9, 2026. https://isco3.org/wp-content/uploads/2017/03/ISCO3-MET-00-01-MAHT-V1-03102016.pdf
4. International Scientific Committee of Ozone Therapy. Non-recommended routes of application in ozone therapy. Published September 5, 2017. Accessed March 9, 2026. https://isco3.org/wp-content/uploads/2015/09/Non-recommended-routes.pdf
5. Martínez Sánchez G, Schwartz A, Quintero Mariño R, Sabbah F. Non-recommended routes of application in ozone therapy, a critical review. Rev Esp Ozonoterapia. 2018;8(1):19-35. Accessed March 9, 2026. https://dialnet.unirioja.es/servlet/articulo?codigo=6553910
6. Hidalgo-Tallón FJ, Torres-Morera LM, Baeza-Noci J, Carrillo-Izquierdo MD, Pinto-Bonilla R. Updated review on ozone therapy in pain medicine. Front Physiol. 2022;13:840623. doi:10.3389/fphys.2022.840623
7. Armenteros-Yeguas V, Gárate-Echenique L, Tomás-López MA, et al. Prevalence of difficult venous access and associated risk factors in highly complex hospitalised patients. J Clin Nurs. 2017;26(23-24):4267-4275. doi:10.1111/jocn.13750
8. Paterson RS, Schults JA, Slaughter E, et al. Peripheral intravenous catheter insertion in adult patients with difficult intravenous access: a systematic review of assessment instruments, clinical practice guidelines and escalation pathways. Emerg Med Australas. 2022;34(6):862-870. doi:10.1111/1742-6723.14069
9. Newcombe RG. Interval estimation for the difference between independent proportions: comparison of eleven methods. Stat Med. 1998;17(8):873-890. doi:10.1002/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I
10. Tertemiz OF, Ozduran E, Gursoy S, et al. Effect of major ozone autohemotherapy in fibromyalgia syndrome: a retrospective study. PeerJ. 2025;13:e20475. doi:10.7717/peerj.20475
11. Gazioğlu Türkyılmaz G, Rumeli Ş, Bakır M. Effects of major ozone autohemotherapy on physical functionality and quality of life in fibromyalgia syndrome: a prospective cross-sectional study. Altern Ther Health Med. 2021;27(5):8-12.
12. Ahi ED, Afsar SI. The effectiveness of major ozone autohemotherapy in the treatment of fibromyalgia syndrome: major ozone autohemotherapy in the treatment of fibromyalgia. J Surg Med. 2022;6(8):746-750. doi:10. 28982/josam.1032050
13. Bocci V. The clinical application of ozonetherapy. In: Bocci V. Ozone: a new medical drug. 2nd ed. Springer; 2011:97-232. doi:10.1007/978-90-481-9234-2_9
14. Wong CYY, Saxena K, Meneer J, George K, Keijzers G. Neurological crisis following intravenous ozone therapy; a case report. Arch Acad Emerg Med. 2025;13(1):e31. doi:10.22037/aaemj.v13i1.2592
15. Khosravi S, Mirzaasgari Z. Cerebral gas embolism and multifocal ischemic stroke during oxygen-ozone therapy: a case report. BMJ Neurol Open. 2024;6(2):e000885. doi:10.1136/bmjno-2024-000885
16. Freund PR, Alshafai L, Margolin EA. Multifocal stroke from ozone gas emboli. J Neuroophthalmol. 2019;39(4):518-519. doi:10.1097/WNO.0000 000000000754
17. He R, Huang Q, Yan X, Liu Y, Yang J, Chen X. A case of paradoxical embolism causing anterior spinal cord syndrome and acute myocardial infarction following the intradiscal oxygen-ozone therapy. Front Neurol. 2019;10:137. doi:10.3389/fneur.2019.00137
Volume 9, Issue 3, 2026
Page : 774-779
_Footer